May 27, 2026 · Form 4 insider transaction
Shaw Christi sold 4,194 shares of Kyverna Therapeutics, Inc. at $8.59 per share, a transaction worth $36.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents the number of shares withheld by and surrendered to the Issuer on May 27, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock unit award for 16,634 shares that vested in full on May 27, 2026.